Nvidia's Nano-X Stake Is From Biotech Deal, Not Direct Buy.

Investors have been following Nvidia's lead and investing in smaller companies after the chipmaker disclosed owning stakes in them. One such company, Nano-X Imaging Ltd., saw its shares double in value over two days, adding $400 million to its market value. However, Nvidia's stake in Nano-X was not a direct purchase but rather a result of Nano-X acquiring Zebra Medical, an Israeli-based startup that Nvidia had a stake in. The market had presumed that Nvidia consciously purchased the stake in Nano-X, but this was not the case. Nano-X shares experienced a decline in postmarket trading after the disclosure. [Extracted from the article]